Niagen Bioscience, Inc. (NAGE) Total liabilities 2017–2025
Niagen Bioscience, Inc. (NAGE) total liabilities at each fiscal year-end, per SEC filings.
$29.9MFY2025 · since FY2017: $8.9M → $29.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $29.9M | +34.7% |
| FY2024 | $22.2M | -16.3% |
| FY2023 | $26.5M | +4.4% |
| FY2022 | $25.4M | -2.8% |
| FY2021 | $26.1M | +19.1% |
| FY2020 | $21.9M | +10.8% |
| FY2019 | $19.8M | +31.5% |
| FY2018 | $15.1M | +69.3% |
| FY2017 | $8.9M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice